ARTICLE | Clinical News
Nebido regulatory update
December 7, 2009 8:00 AM UTC
FDA issued a complete response letter for an NDA from Endo for Aveed to treat male hypogonadism. The company said FDA requested information regarding serious adverse events, including post-injection a...